New Data at the 2021 ASTS Winter Symposium to Showcase Benefit of Serial Prospera™ Testing
New Data at the 2021 ASTS Winter Symposium to Showcase Benefit of Serial Prospera™ Testing News provided by Share this article SAN CARLOS, Calif., Jan. 14, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the Prospera test at the American Society of Transplant Surgeons (ASTS) 21st Annual Winter Symposium, taking place January 14-16, 2021. Natera will present five posters, featuring ca...
Source: prnewswire.com